MedWatch

Head of research at Novo steps down after 17 years in the office

Novo Nordisk's long-term Senior Vice President of Global Research Peter Kurtzhals has decided to step down from the position he has held for 17 years. It happens due to health reasons and triggers a number of changes in the organization.

Peter Kurtzhals, direktør for diabetesforskningen i Novo Nordisk
Peter Kurtzhals, Senior Vice President of Global Research at Novo Nordisk, steps down effective immediately from his current position after 17 years. He will stay in the organization, but in a different capacity.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Nyt milliontab i Labflex

For andet år i træk viser regnskabet for laboratoriefirmaet Labflex et stort underskud. Ledelsen forventer for 2018 endnu et år med tab.

David Solomon lander nyt topjob

Mindre end tre måneder efter at være trådt tilbage som adm. direktør i amerikansk biotekselskab efter kontrovers om brug af et kreditkort er den tidligere Zealand Pharma-topchef David Solomon atter tilbage i direktørstolen. Denne gang i et britisk biotekselskab.

Related articles